This Biotech Is Up 194% in a Year but One Investor Took Millions Off the Table

3 weeks ago 18

Jonathan Ponciano, The Motley Fool

Sun, December 28, 2025 astatine 11:56 AM CST 5 min read

Oregon-based Stonepine Capital Management reduced its Indivior involvement by 250,000 shares successful the 3rd quarter.
The wide presumption worth fell by astir $2.75 cardinal from the erstwhile period.
As of September 30, the money reported holding 100,000 INDV shares valued astatine $2.41 million.
These 10 stocks could mint the adjacent question of millionaires ›

Oregon-based Stonepine Capital Management reported a merchantability of 250,000 shares of Indivior PLC (NASDAQ:INDV), reducing its presumption by astir $2.75 million, according to a November 13 SEC filing.

According to a Securities and Exchange Commission (SEC) filing dated November 13, Stonepine Capital Management sold 250,000 shares of Indivior PLC (NASDAQ:INDV) during the 3rd quarter. The transaction led to a alteration successful the fund’s presumption worth by astir $2.75 million, bringing its Indivior holding to 100,000 shares worthy $2.41 cardinal astatine quarter-end.

Stonepine's Indivior presumption present represents 1.96% of reportable AUM, down from 5.06% the erstwhile quarter.

Top holdings aft the filing:

NASDAQ:VSTM: $23.58 cardinal (19.17% of AUM)
NASDAQ:ADMA: $10.83 cardinal (8.81% of AUM)
NASDAQ:EOLS: $9.43 cardinal (7.67% of AUM)
NASDAQ:ZVRA: $7.70 cardinal (6.26% of AUM)
NASDAQ:NKTR: $4.84 cardinal (3.93% of AUM)

As of Friday, Indivior shares were priced astatine $36.21, up a staggering 194% implicit the past twelvemonth and vastly outperforming the S&P 500, which is up astir 15% successful the aforesaid period.

Metric

Value

Price (as of Friday)	$36.21
Market Capitalization	$4.53 billion
Revenue (TTM)	$1.18 billion
Net Income (TTM)	$124.00 million

Indivior PLC develops and markets buprenorphine-based medicine drugs for opioid dependence, arsenic good arsenic treatments for substance usage disorders, opioid overdose, and schizophrenia. Key products see SUBLOCADE, SUBUTEX PRO, SUBOXONE, OPVEE, and PERSERIS.
The institution generates gross chiefly done the merchantability of branded pharmaceutical products, with a absorption connected long-acting injectable therapies and sublingual formulations targeting opioid usage upset and related conditions.
Indivior's superior customers are healthcare providers, attraction centers, and authorities agencies addressing opioid addiction and intelligence wellness disorders successful the United States and planetary markets.

Indivior PLC is simply a specialty pharmaceutical institution with a starring presumption successful the attraction of opioid usage upset and related behavioral wellness conditions. The institution leverages a divers portfolio of proprietary therapies and invests successful innovative pipeline assets targeting substance usage and intelligence wellness disorders.